Lista de obras - Shirley Hodgson - Dominio Público Uruguay

A complex endocrine conundrum

artículo científico publicado en 2013

APC mutation associated with late onset of familial adenomatous polyposis

artículo científico publicado en 1994

AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study

artículo científico publicado en 2007

Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United Kingdom

artículo científico publicado en 2006

Allelic loss at SMAD4 in polyps from juvenile polyposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

artículo científico publicado en 2015

Association between polymorphisms of the GPX1 gene and second primary tumours after index squamous cell cancer of the head and neck

artículo científico publicado en 2005

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

artículo científico publicado en 2015

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2

artículo científico publicado en 2012

Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study

artículo científico publicado en 2011

CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer

artículo científico publicado en 2015

Cancer genetics services in Europe

artículo científico publicado en 1999

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

artículo científico publicado en 2013

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk

artículo científico publicado en 2015

Changes in psychological distress after cancer genetic counselling: a comparison of affected and unaffected women

artículo científico publicado en 2002

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction

artículo científico publicado en 2010

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

artículo científico publicado en 2012

Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

scientific article published on 05 August 2009

Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer

artículo científico publicado en 2015

Current Policies for Surveillance and Management in Women at Risk for Breast and Ovarian Cancer: A Survey among 16 European Family Cancer Clinics

Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group

artículo científico publicado en 1998

DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Diagnosis and Management of Hereditary Thyroid Cancer

artículo científico publicado en 2016

Does the occurrence of certain rare cancers indicate an inherited cancer susceptibility?

Emberger syndrome-Primary lymphedema with myelodysplasia: Report of seven new cases

artículo científico publicado en 2010

Ethical, social and economic issues in familial breast cancer: a compilation of views from the E.C. Biomed II Demonstration Project

artículo científico publicado en 1999

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2017

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).

artículo científico publicado en 2009

Exploring the link between MORF4L1 and risk of breast cancer

artículo científico publicado en 2011

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2016

Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk

artículo científico publicado en 2014

Five endometrial cancer risk loci identified through genome-wide association analysis

artículo científico publicado en 2016

GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer

artículo científico

Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer

artículo científico publicado en 2016

Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders

artículo científico publicado en 2011

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2010

Genome-wide allelotyping of 104 Finnish colorectal cancers reveals an excess of allelic imbalance in chromosome 20q in familial cases

artículo científico publicado en 2003

Genome-wide association study identifies a common variant associated with risk of endometrial cancer

artículo científico publicado en 2011

Genome-wide association study identifies a possible susceptibility locus for endometrial cancer

artículo científico publicado en 2012

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

artículo científico publicado en 2013

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study ⬇️

artículo científico publicado en 2018

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer

artículo científico publicado en 2013

Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia

artículo científico publicado en 2007

Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers.

artículo científico publicado en 2003

Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer

artículo científico publicado en 1999

Guidelines for the clinical management of familial adenomatous polyposis (FAP).

artículo científico publicado en 2008

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2011

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

artículo científico publicado en 2017

Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions

artículo científico publicado en 1999

Identification of germline missense mutations and rare allelic variants in theATM gene in early-onset breast cancer

article

Identification of nine new susceptibility loci for endometrial cancer

artículo científico publicado en 2018

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

artículo científico publicado en 2017

Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe

artículo científico publicado en 1999

Large genomic deletions in AIP in pituitary adenoma predisposition.

artículo científico publicado en 2008

Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom.

artículo científico publicado en 2006

Low prevalence of germline BRCA1 mutations in early onset breast cancer without a family history

artículo científico publicado en 2000

Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status

artículo científico publicado en 2014

Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers.

artículo científico publicado en 2006

Mechanisms of inherited cancer susceptibility

artículo científico publicado en 2008

Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer

artículo científico publicado en 2020

Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.

artículo científico publicado en 2015

Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis

artículo científico publicado en 2002

Mutation-Specific Survival of Inherited Breast Cancer

artículo científico publicado en 1999

Mutations and alternative splicing of theBRCA1 gene in UK breast/ovarian cancer families

article

Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases.

artículo científico publicado en 1998

Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)

article by Pia Ostergaard et al published 4 September 2011 in Nature Genetics

No evidence of RET germline mutations in familial pituitary adenoma.

artículo científico publicado en 2010

No evidence that GATA3 rs570613 SNP modifies breast cancer risk

scientific article published on 11 December 2008

Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3.

artículo científico publicado en 1998

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

artículo científico publicado en 2017

Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer

artículo científico publicado en 1999

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2017

Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome

artículo científico publicado en 1999

Sequence changes in predicted promoter elements of STK11/LKB1 are unlikely to contribute to Peutz-Jeghers syndrome

artículo científico publicado en 2005

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study

artículo científico publicado en 2014

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

artículo científico publicado en 2010

The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine

artículo científico publicado en 2010

UBE2QL1 is disrupted by a constitutional translocation associated with renal tumor predisposition and is a novel candidate renal tumor suppressor gene

artículo científico publicado en 2013

Utilisation of prophylactic mastectomy in 10 European centres

artículo científico publicado en 1999

What motivates interest in attending a familial cancer genetics clinic?

artículo científico publicado en 2003

Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas

artículo científico publicado en 2002

Lista de obras de Shirley Hodgson

A complex endocrine conundrum

APC mutation associated with late onset of familial adenomatous polyposis

AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study

Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United Kingdom

Allelic loss at SMAD4 in polyps from juvenile polyposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

Association between polymorphisms of the GPX1 gene and second primary tumours after index squamous cell cancer of the head and neck

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2

Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study

CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer

Cancer genetics services in Europe

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk

Changes in psychological distress after cancer genetic counselling: a comparison of affected and unaffected women

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer

Current Policies for Surveillance and Management in Women at Risk for Breast and Ovarian Cancer: A Survey among 16 European Family Cancer Clinics

Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group

DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers

Diagnosis and Management of Hereditary Thyroid Cancer

Does the occurrence of certain rare cancers indicate an inherited cancer susceptibility?

Emberger syndrome-Primary lymphedema with myelodysplasia: Report of seven new cases

Ethical, social and economic issues in familial breast cancer: a compilation of views from the E.C. Biomed II Demonstration Project

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).

Exploring the link between MORF4L1 and risk of breast cancer

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk

Five endometrial cancer risk loci identified through genome-wide association analysis

GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer

Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer

Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

Genome-wide allelotyping of 104 Finnish colorectal cancers reveals an excess of allelic imbalance in chromosome 20q in familial cases

Genome-wide association study identifies a common variant associated with risk of endometrial cancer

Genome-wide association study identifies a possible susceptibility locus for endometrial cancer

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study ⬇️

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer

Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia

Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers.

Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer

Guidelines for the clinical management of familial adenomatous polyposis (FAP).

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions

Identification of germline missense mutations and rare allelic variants in theATM gene in early-onset breast cancer

Identification of nine new susceptibility loci for endometrial cancer

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe

Large genomic deletions in AIP in pituitary adenoma predisposition.

Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom.

Low prevalence of germline BRCA1 mutations in early onset breast cancer without a family history

Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status

Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Mechanisms of inherited cancer susceptibility

Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer

Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.

Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis

Mutation-Specific Survival of Inherited Breast Cancer

Mutations and alternative splicing of theBRCA1 gene in UK breast/ovarian cancer families

Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases.

Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)

No evidence of RET germline mutations in familial pituitary adenoma.

No evidence that GATA3 rs570613 SNP modifies breast cancer risk

Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3.

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome

Sequence changes in predicted promoter elements of STK11/LKB1 are unlikely to contribute to Peutz-Jeghers syndrome

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study